Katalin Kauser, PhD, MD, Sc.D
Katalin Kauser is the Senior Vice President of Translational Biology at Metageomi. Katalin brings more than 30+ years of leadership experience in the biotech and pharmaceutical industries, specializing in drug discovery and preclinical development from target identification and validation through regulatory submission and early clinical development.
SVP, Translational Biology
Katalin’s experience spans multiple therapeutic areas — including hematology, cardiovascular, pulmonary, and metabolic diseases — and modalities such as small molecules, biologics, gene therapy, and medical devices. Prior to joining Metagenomi, she held executive and scientific leadership positions at Alucent Biomedical, Global Blood Therapeutics, Bayer, Boehringer Ingelheim, and Berlex Biosciences.
Katalin received her MD from Semmelweis Medical University and her PhD and DSc from the Hungarian Academy of Sciences in Budapest, Hungary.